Delivery Order SPE2DB22D9316-SPE2DB25FYP96
Award Date 9/2/25
Potential Completion Date 9/23/25
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,525.54 by the Defense Logistics Agency (DLA) on June 30, 2025, with an ultimate completion date of July 22, 2025. The delivery order covers the supply of Tysabri (natalizumab) 300 mg/15 ml vials, a biologic immunosuppressant medication used to treat multiple sclerosis and Crohn's disease. This award was made without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $52,627.70 firm fixed-price delivery order from the Defense Logistics Agency on September 4, 2025, for TYSABRI 300 mg/15 ml vials. The contract, with an ultimate completion date of September 25, 2025, carries no set-aside designation and represents performance at the company's Park Ridge, Illinois location. This delivery order falls under DMS Pharmaceutical Group's...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $41,265.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Tysabri 300 mg/15 ml vials over a period ending on May 15, 2024. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $5,262.76 for 4,569,009,975 units of Tysabri 300 mg/15 ml vials. The contract, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation. Performance will be fulfilled from the vendor's Park Ridge facility. Tysabri is a biologic medication...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $52,627.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYSABRI 300 mg/15 mL vials. This firm fixed-price delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a specific procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,262.76 to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of TYSABRI 300 mg/15 ml vials. This firm fixed-price delivery order is scheduled for completion by September 9, 2025, with performance taking place at the vendor's facility in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,788.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tysabri 300 mg/15 ml vials. This firm fixed-price delivery order, awarded on June 2, 2025, with an ultimate completion date of June 24, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group is executing this order under its existing Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $10,316.36 firm fixed-price delivery order contract is for the supply of TYSABRI 300 MG/15 ML VIAL 15ML, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2024 and does not have a set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract,...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tysabri 300 mg/15 ml vials. The contract, valued at $21,051.08 with a firm fixed-price structure, was executed on September 16, 2025, with an ultimate completion date of October 7, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $52,627.70 firm fixed-price delivery order is for TYSABRI 300 MG/15 ML VIAL 15ML, with a period of performance through August 7, 2025. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with DLA valued at $499,999,999, which allows the agency to issue delivery orders...